Regional Diffusion of Botulinum Toxin in Facial Muscles: A Randomised Double-blind Study and a Consideration for Clinical Studies with Split-face Design

Authors

  • Anna Rostedt Punga
  • Annika Eriksson
  • Mohammad Alimohammadi

DOI:

https://doi.org/10.2340/00015555-2093

Keywords:

Key words: botulinum toxin, glabellar muscles, frontalis, CMAP, split-face

Abstract

Despite the extensive use of botulinum toxin A (BoNTA) in medical and cosmetic treatments, the potential spreading of BoNTA to surrounding tissues remains unknown. A patient with hemifacial paralysis upon blepharospasm treatment with low dose of BoNTA, prompted us to investigate the spreading effect. A randomised, double-blind study was conducted in which 5 healthy women (33–52 years) were treated with different doses of onabotulinum toxin unilaterally in the corrugator muscle. Parameters of efficacy and diffusion (CMAP; EMG and jitter analysis) in both glabellar and frontalis muscles were assessed at baseline, 2 and 4 weeks following BoNTA injection. CMAP of the treated glabellar muscles was reduced to approximately 40% in all dose groups. Additionally, contralateral CMAP reduction was observed in 3 of 5 subjects. These data confirm regional diffusion of BoNTA in facial muscle application, which raises question on the reliability of split-face models in BoNTA studies.

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2015-04-22

How to Cite

Rostedt Punga, A., Eriksson, A., & Alimohammadi, M. (2015). Regional Diffusion of Botulinum Toxin in Facial Muscles: A Randomised Double-blind Study and a Consideration for Clinical Studies with Split-face Design. Acta Dermato-Venereologica, 95(8), 948–951. https://doi.org/10.2340/00015555-2093

Issue

Section

Articles